Ultrasonographical predictive factors of ovarian response to stimulation prior to in vitro fertilization;Facteurs échographiques prédictifs de la réponse ovarienne en fécondation in vitro

Gynecologie Obstetrique et Fertilite

Volumn 33, Issue 10, 2005, Pages 762-767

  Ebrard Charra, S ^a   Reyftmann, L ^a   Hedon B ^a   Dechaud H ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Antral follicles; Ovarian response; Ovarian volume; Transvaginal ultrasonography

Indexed keywords

FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; FEMALE; FERTILIZATION IN VITRO; HUMAN; MENSTRUATION; OOCYTE; OUTCOMES RESEARCH; OVARY; PROSPECTIVE STUDY;

EID: 25144523923     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2005.06.020     Document Type: Article

References (26)

1. J.P. Toner, and J.T. Flood Fertility after the age of 40 Obstet. Gynecol. Clin. North Am. 20 1993 261 272
2. M.V. Sauer, R.J. Paulson, and R.A. Lobo Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age JAMA 268 1992 1320 1321
3. R.T. Scott, J.P. Toner, S.J. Muasher, S. Oehninger, S. Robinson, and Z. Rosenwaks Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome Fertil. Steril. 51 1989 651 654
4. J.P. Toner, C.B. Philput, G.S. Jones, and S.J. Muasher Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age Fertil. Steril. 55 1991 784 791
5. R.T. Scott Jr., G.E. Hofmann, S. Oehninger, and S.J. Muasher Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization Fertil. Steril. 54 1990 297 302
6. B. H́don, H. D́chaud, F. Galtier-Dereure, and N. Guigue Comment ́valuer la ŕserve ovarienne en 1999:? Contracept. Fertil. Sex. 27 1999 412 416
7. F.L. Licciardi, H.C. Liu, and Z. Rosenwaks Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization Fertil. Steril. 64 1995 991 994
8. D.B. Seifer, G. Lambert-Messerlian, J.W. Hogan, A.C. Gardiner, A.S. Blazar, and C.A. Berk Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome Fertil. Steril. 67 1997 110 114
9. A.L. Durlinger, M.J. Gruijters, P. Kramer, B. Karels, T.R. Kumar, and M.M. Matzuk Antimullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary Endocrinology 142 2001 4891 4899
10. C. Tomas, S. Nuojua-Huttunen, and H. Martikainen Pretreatment transvaginal ultrasound examination predictsovarianresponsiveness to gonadotrophins in in-vitro fertilization Hum. Reprod. 12 1997 220 223
11. P.Y. Yong, D.T. Baird, K.J. Thong, A.S. McNeilly, and R.A. Anderson Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation Hum. Reprod. 18 2003 35 44
12. A. Lass, J. Skull, E. McVeigh, R. Margara, and R.M. Winston Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response Hum. Reprod. 12 1997 294 297
13. J.L. Frattarelli, A.J. Levi, B.T. Miller, and Segars A prospective assessment of the predictive value of basal antral follicles in in vitrofertilization cycles Fertil. Steril. 80 2003 350 355
14. M.Y. Chang, C.H. Chiang, T.T. Hsieh, Y.K. Soong, and K.H. Hsu Use of the antral follicle count to predict the outcome of assisted reproductive technologies Fertil. Steril. 69 1998 505 510
15. K.R. Hansen, J.L. Morris, A.C. Thyer, and M.R. Soules Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting Fertil. Steril. 80 2003 577 583
16. S. Kupesic, and A. Kurjak Predictors of IVF outcome by three-dimensional ultrasound Hum. Reprod. 17 2002 950 955
17. A. Kyei-Mensah, J. Zaidi, R. Pittrof, A. Shaker, S. Campbell, and S.L. Tan Transvaginal three-dimensional ultrasound: accuracy of follicular volume measurements Fertil. Steril. 65 1996 371 376
18. M.H. Wu, H.H. Tang, C.C. Hsu, S.T. Wang, and K.E. Huang The role of three-dimensional ultrasonographic images in ovarian measurement Fertil. Steril. 69 1998 1152 1155
19. I.A. Van Rooij, L.F. Bancsi, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. Te Velde Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in vitro fertilization Fertil. Steril. 79 2003 482 488
20. I.A. Van Rooij, E. De Jong, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. Te Velde High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment Fertil. Steril. 81 2004 1478 1485
21. J.P. Toner Age = egg quality, FSH level = egg quantity Fertil. Steril. 79 2003 491
22. M. Creus, J. Peñarrubia, F. Fábregues, E. Vidal, F. Carmona, and R. Casamitjana Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome Hum. Reprod. 15 2000 2341 2346
23. A. Hazout Les facteurs de ŕserve ovarienne. Livre des conf́rences pŕsent́ lors des huitìmes jourńes de le F́d́ration fraņaise d'́tude de la reproduction 2003 (p. 14-16)
24. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil. Steril. 77 2002 468 471
25. R. Fanchin, L.M. Schonauer, C. Righini, J. Guibourdenche, R. Frydman, and Taieb Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3 Hum. Reprod. 18 2003 323 327
26. A. Hazout, P. Bouchard, D.B. Seifer, P. Aussage, A.M. Junca, and P. Cohen-Bacrie Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol Fertil. Steril. 82 2004 1323 1329